Mymetics Corp (MYMX)

[Work Harder]

Likewise, Lakhashe et al. show that systemic priming followed by intranasal boosting with a virosomal HIV-1 gp41 vaccine in nonhuman primates can induce specific antibodies in both serum and vaginal secretions, and confer protection against low dose vaginal SHIV challenge.

Siqi Gong1,2, Samir K. Lakhashe1, Dinesh Hariraju1,2, Hanna Scinto1,3, Antonio Lanzavecchia4,5, Elisabetta Cameroni4,5, Davide Corti4,5, Sarah J. Ratcliffe6, Kenneth A. Rogers2,7, Peng Xiao2, Jane Fontenot2, François Villinger2,7 and Ruth M. Ruprecht1,2,3,7*

1 Texas Biomedical Research Institute, San Antonio, TX, United States
2 New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA,United States
3 Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, United States
4 Institute for Research in Biomedicine, Bellinzona, Switzerland
5 Humabs BioMed, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland
6 University of Pennsylvania, Philadelphia, PA, United States
7 Department of Biology, University of Louisiana at Lafayette, Lafayette, LA, United States

Doesn't that make Mymx worth what Vir {that Gsk & B&MGF has equity in} paid for Humabs BioMed b/c even without knowing that number Mymx is worth way more than it's current stock price which concludes my DD here :}

Later brother